A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.

Clinical trial NCT05582187 · COMPLETED

Trial details

NCT number: NCT05582187
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2022-10-31
Primary completion: 2025-10-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.